Clinical trial design in phase 2 and 3 trials for pulmonary hypertension

Παρόμοια τεκμήρια

• Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension
  ανά: Sitbon, Olivier, κ.ά.
  Έκδοση: (2020)
• The Innovative Drug Development Initiative (IDDI) of the Pulmonary Vascular Research Institute (PVRI)
  ανά: Paul A Corris, κ.ά.
  Έκδοση: (2020-11-01)
• The Innovative Drug Development Initiative (IDDI) of the Pulmonary Vascular Research Institute (PVRI): A series of four guidance documents for academics, drug regulators and industry partners
  ανά: Corris, Paul A, κ.ά.
  Έκδοση: (2020)
• Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension
  ανά: Howard, Luke S.G.E., κ.ά.
  Έκδοση: (2013)
• Updating clinical endpoints in pulmonary arterial hypertension: when challenges are welcome
  ανά: Hassoun, Paul M., κ.ά.
  Έκδοση: (2013)